Skip to main content
Disparities in Oncology Care
Oral Parity Laws Could Reduce Disparities in Cancer Care
Chase Doyle
Read More
Clinical Trials
Patient-Centered Clinical Pathways Should Incorporate the Patient’s Voice
Chase Doyle
Read More
Financial Toxicity High for Low-Income Patients in Early-Phase Clinical Trials
Chase Doyle
Read More
FDA Updates
Nubeqa New Oral Therapy FDA Approved for Nonmetastatic Prostate Cancer
Read More
FDA Updates
Turalio First FDA-Approved Systemic Therapy for Tenosynovial Giant-Cell Tumor
Read More
FDA Updates
Rozlytrek Third FDA-Approved Tumor-Agnostic Drug and Second Treatment for Patients with NTRK Fusion Tumors
Read More
Meeting Highlights
Breast Cancer, ESMO Highlights, CDK4/6 Inhibitors
Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care
Phoebe Starr
Read More
Head and Neck Cancer
Oral Cancer and Sex in the Era of HPV Infection
Meg Barbor, MPH
Read More
Ovarian Cancer, FDA Updates
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer, Multiple Myeloma, Pediatric Cancer, FDA Updates
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
Page 146 of 196
Results 1451 - 1460 of 1954